Indication
Type IA
2 clinical trials
2 products
Product
EN001Clinical trial
Open-label, Dose-escalation, Phase 1 Clinical Trial to Determine the Safety and Dose of EN001 in Patients With Charcot-Marie-Tooth Disease (CMT) Type 1AStatus: Completed, Estimated PCD: 2022-12-20
Clinical trial
International, Multi-center, Open Label, Follow-up Extension Study Assessing the Long-term Safety and Tolerability of PXT3003 in Patients With Charcot-Marie-Tooth Disease Type 1AStatus: Active (not recruiting), Estimated PCD: 2024-12-31
Product
PXT3003